1.3K(top 11%)
articles
80.3K(top 6%)
citations
575(top 7%)
★★ articles
64(top 4%)
★★★ articles
4.7(top 4%)
Avg IF
122(top 5%)
H-Index
262(top 4%)
G-Index
375
journals

Most Cited Articles of Alvin J. Siteman Cancer Center in 2015

TitleJournalYearCitations
An integrated map of structural variation in 2,504 human genomesNature20151.4K
Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexesNature Genetics2015547
Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemiaNature2015503
Safety and survival with GVAX pancreas prime and Listeria Monocytogenes-expressing mesothelin (CRS-207) boost vaccines for metastatic pancreatic cancerJournal of Clinical Oncology2015398
Convergent loss of PTEN leads to clinical resistance to a PI(3)Kα inhibitorNature2015366
Mechanisms of aromatase inhibitor resistanceNature Reviews Cancer2015233
Prevalence of Overweight and Obesity in the United States, 2007-2012JAMA Internal Medicine2015188
Patterns and functional implications of rare germline variants across 12 cancer typesNature Communications2015170
Genomic analysis of germ line and somatic variants in familial myelodysplasia/acute myeloid leukemiaBlood2015150
TH2-Polarized CD4(+) T Cells and Macrophages Limit Efficacy of RadiotherapyCancer Immunology Research2015146
Optimizing cancer genome sequencing and analysisCell Systems2015135
Outcomes of transformed follicular lymphoma in the modern era: a report from the National LymphoCare Study (NLCS)Blood2015124
The genomic landscape of childhood and adolescent melanomaJournal of Investigative Dermatology2015121
Broad Anti-tumor Activity of a Small Molecule that Selectively Targets the Warburg Effect and LipogenesisCancer Cell2015116
Systematic review of falls in older adults with cancerJournal of Geriatric Oncology2015100
Breastfeeding and breast cancer risk by receptor status--a systematic review and meta-analysisAnnals of Oncology201595
Randomized controlled trial of irinotecan drug-eluting beads with simultaneous FOLFOX and bevacizumab for patients with unresectable colorectal liver-limited metastasisCancer201593
18F-fluoride PET used for treatment monitoring of systemic cancer therapy: results from the National Oncologic PET RegistryJournal of Nuclear Medicine201572
Radiofrequency ablation and vertebral augmentation for palliation of painful spinal metastasesJournal of Neuro-Oncology201571
Repeatability of 18F-FDG PET/CT in Advanced Non-Small Cell Lung Cancer: Prospective Assessment in 2 Multicenter TrialsJournal of Nuclear Medicine201569
Evaluation of Urine Aquaporin-1 and Perilipin-2 Concentrations as Biomarkers to Screen for Renal Cell Carcinoma: A Prospective Cohort StudyJAMA Oncology201562
A CDC20-APC/SOX2 Signaling Axis Regulates Human Glioblastoma Stem-like CellsCell Reports201561
Genome Modeling System: A Knowledge Management Platform for GenomicsPLoS Computational Biology201559
HER2-Mutated Breast Cancer Responds to Treatment With Single-Agent Neratinib, a Second-Generation HER2/EGFR Tyrosine Kinase InhibitorJournal of the National Comprehensive Cancer Network: JNCCN201557
HER2 missense mutations have distinct effects on oncogenic signaling and migrationProceedings of the National Academy of Sciences of the United States of America201551